UBS reiterated its buy rating on private shares of SpaceX ahead of the company's fourth integrated flight test of its Starship rocket, according to an analyst note published July 15, 2026. The Swiss investment bank sees the launch as a critical milestone for validating the fully reusable launch system. A successful test could significantly accelerate SpaceX's ambitious timeline for satellite deployment and deep space missions.
Context — [why this matters now]
SpaceX is targeting its fourth major orbital test flight for its Starship system, the most powerful rocket ever built. The previous test in March 2026 achieved several objectives, including a successful ascent and stage separation, but the vehicle was lost during re-entry. Each test builds on data from prior flights, with this iteration focused on demonstrating re-entry survivability and a controlled splashdown.
The commercial space sector is experiencing rapid growth, driven by increased satellite demand for communications and earth observation. Global private investment in space ventures exceeded $25 billion in 2025. Federal interest rates at 5.25% have tightened capital availability, placing greater emphasis on companies demonstrating clear technological progress and near-term revenue potential.
This test is a key catalyst for SpaceX's operational capabilities. Starship is designed to launch the company's next-generation Starlink satellites more efficiently and support a planned lunar landing mission for NASA. Successful development is fundamental to SpaceX achieving its stated goal of drastically reducing launch costs.
Data — [what the numbers show]
SpaceX achieved a valuation of $210 billion during its last private funding round in late 2025. UBS has not publicly disclosed its price target for the privately traded shares. The company's Starlink division has surpassed 4 million active subscribers, generating an estimated annual revenue run rate of $8 billion.
Starship is designed to carry a payload capacity of over 100 metric tons to low Earth orbit, a significant increase over the Falcon 9's 22.8-ton capacity. This represents a 338% increase in potential payload mass per launch. Development costs for the Starship program are estimated to exceed $10 billion to date.
Comparatively, legacy aerospace contractor Boeing has a market capitalization of $115 billion. Rocket Lab, a smaller public competitor, has a market cap of $2.5 billion. SpaceX's valuation reflects its dominant market share in commercial launch services and its ownership of the Starlink network.
Analysis — [what it means for markets / sectors / tickers]
A successful Starship test would positively impact companies across the satellite and space ecosystem. Satellite manufacturers like Maxar Technologies [MAXR] and AST SpaceMobile [ASTS] would benefit from lower future launch costs, potentially improving their unit economics. Earth observation companies like Planet Labs [PL] could accelerate their constellation refresh cycles.
Traditional aerospace contractors face competitive pressure from SpaceX's lower cost structure. Boeing [BA] and Lockheed Martin [LMT], partners in the United Launch Alliance, could see their market share in the national security launch sector challenged further. These companies are developing their own next-generation vehicles but remain years behind SpaceX's testing cadence.
The primary risk to the thesis is another test failure delaying the program and increasing capital burn. SpaceX relies on periodic capital raises, and any significant development setback could impact its valuation in secondary markets. Institutional flow data shows continued strong buyer interest in private market transactions, with shares trading at a premium to the last funding round.
Outlook — [what to watch next]
The immediate catalyst is the outcome of the Starship test flight, scheduled for no earlier than July 18, 2026. Key milestones to watch include successful stage separation, engine re-ignition, and controlled re-entry. NASA will monitor the test closely ahead of its planned Artemis III lunar landing mission, which depends on Starship.
Investors should watch for a Starlink initial public offering filing, which management has suggested could occur once cash flow becomes more predictable. The next major valuation inflection point will be SpaceX's subsequent private funding round, expected in early 2027. Key levels to watch are the company's burn rate and progress toward Starship operational status.
Frequently Asked Questions
How can retail investors buy SpaceX stock?
SpaceX is a privately held company, so its shares are not available on public exchanges. Retail access is typically limited to accredited investors through special purpose vehicles or secondary market platforms like Forge Global or Rainmaker Securities. These platforms facilitate trades of pre-IPO shares but often require high minimum investments and carry significant liquidity risk.
What is the historical success rate of SpaceX's Starship tests?
SpaceX has conducted three previous integrated flight tests of its Starship system. The first test in April 2023 ended shortly after launch due to multiple engine failures. The second test in November 2023 achieved stage separation but ended with a flight termination. The third test in March 2026 reached orbital velocity but was lost during re-entry, marking the most successful flight to date.
How does Starship compare to NASA's Space Launch System?
NASA's Space Launch System is a government-developed heavy-lift rocket designed for deep space missions. The SLS has flown once successfully, launching the Artemis I mission in 2022. Starship is a fully reusable commercial system with a higher payload capacity and a fundamentally different design philosophy focused on extremely low cost per launch. SLS cost per launch is estimated above $2 billion, while SpaceX targets eventually below $10 million.
Bottom Line
UBS views SpaceX's upcoming Starship test as a critical valuation catalyst for the private space company.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
